Pharmafile Logo

#RemoteDetailing

EU flag

Updated EMA reports better suited to HTA needs

Changes to drug licensing reports are helping to support reimbursement decisions

Microsoft to back new wave of health startups

Technology giant's venture arm partners with Becton Dickinson on new programme

- PMLiVE

Vertex will file combination cystic fibrosis therapy this year

Data supports use of lumacaftor alongside Kalydeco

- PMLiVE

Janssen-backed report calls on governments to tackle hepatitis C

Report finds that national policies do not adequately address disease

- PMLiVE

Eisai names new US financial head

Barry Lederman joins as chief financial officer

- PMLiVE

Ashfield partners with collaboration specialist

Will work with Within3 to develop new services

- PMLiVE

Niche-busting cancer immunotherapies

Targeted oncology treatments are a reason for hope

- PMLiVE

Langland steals the pharma show at first Lions Health

But judges decide no industry work deserves this year's Grand Prix

- PMLiVE

Merck KGaA furthers antibody ambitions in cancer

Signs deal with Mersana to develop antibody-drug conjugates

Shire Basingstoke

Shire spells out why AbbVie takeover is a bad idea

Talks up its growth prospects as an independent company

- PMLiVE

Abbott offers up to $495m for Russia’s Veropharm

Acquisition will add to its generics portfolio

- PMLiVE

Pharma needs to make better use of data

Survey finds industry is more concerned with data breaches than analysis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links